As obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a role.

My own experience initially led me to believe that weight loss was just a matter of commitment and a modicum of self-control.

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

2024 — A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 ...

SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRNX) today announced that on October 10, 2024, the Compensation ...

MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial-targeted sulfide-donor therapeutics (mtH2SD) in obesity-related disorders and myopathies announces a ...

Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer Inc. and is seeking to spur a turnaround of ...

Fasting may have potential health benefits for some people, including weight loss, heart health, blood sugar control, brain ...

The steepest rise in new breast cancer cases is among women under 50, according to the American Cancer Society.

This innovative approach, which combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) with semaglutide, resulted in the elimination of insulin therapy for 86% of ...

By eliminating certain gut bacteria and inducing stress, researchers were able to conclude a relationship between stress and gut microbiota in the progression of CRC, identifying a particular ...

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...